ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

83
Analysis
Health Care β€’ Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
β€’09 Jun 2024 15:02

Quiddity TDIV/50/100 Jun 24 Rebal: 15/18 Hits; Updated Flow Expectations and Trade Ideas

We estimate one-way flow for the TDIV June 2024 rebal to be around US$1.08bn which translates to a turnover of 17%. We expect the top outflow names...

Share
bearishβ€’Quantitative Analysis
β€’27 May 2024 07:05

TWSE Short Interest Weekly (May 24th): Asustek Computer, Realtek Semi, Evergreen Marine

We analyzed TWSE short interest report for the past week and highlighted short interest changes in Asustek Computer, Realtek Semi, Evergreen...

Logo
365 Views
Share
bullishβ€’Quantitative Analysis
β€’22 Apr 2024 07:05

TWSE Short Interest Weekly (Apr 19th): TSMC, Wiwynn, Tatung, Umc, Teco Elec & Mach, Quanta Computer

We analyzed TWSE short interest report for the past week and highlighted short interest changes in TSMC, Wiwynn, Tatung, Umc, Teco Elec & Mach,...

Logo
359 Views
Share
x